Direct Injection Liquid Brachytherapy Therapeutic Radioisotope Procedures For Canince Cancer

PharmaCom BioVet, Inc. (PINKSHEETS: PHMB) is pleased to announce its plans with IsoTherapeutics Group, LLC to explore the latest ground-breaking direct injection liquid brachytherapy therapeutic radioisotope procedures* for use within its canine cancer treatment centers. As part of its plans for state-of-the-art treatment centers for canine lymphoma and other forms of cancer, PharmaCom BioVet, Inc.

More: continued here

Filed under: Veterinary on October 27th, 2008